These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34979197)

  • 1. Arborinine suppresses ovarian cancer development through inhibition of LSD1.
    Li N; Yang L; Zuo H
    Life Sci; 2022 Feb; 291():120275. PubMed ID: 34979197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arborinine, a potential LSD1 inhibitor, inhibits epithelial-mesenchymal transition of SGC-7901 cells and adriamycin-resistant gastric cancer SGC-7901/ADR cells.
    Chu Y; Xiao Z; Jing N; Yan W; Wang S; Ma B; Zhang J; Li Y
    Invest New Drugs; 2021 Jun; 39(3):627-635. PubMed ID: 33215324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-302 represses epithelial-mesenchymal transition and cisplatin resistance by regulating ATAD2 in ovarian carcinoma.
    Ge T; Liu T; Guo L; Chen Z; Lou G
    Exp Cell Res; 2020 Nov; 396(1):112241. PubMed ID: 32835657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KDM1A/LSD1 inhibition enhances chemotherapy response in ovarian cancer.
    Chen Y; Johnson JD; Jayamohan S; He Y; Venkata PP; Jamwal D; Alejo S; Zou Y; Lai Z; Viswanadhapalli S; Vadlamudi RK; Kost E; Sareddy GR
    Mol Carcinog; 2024 Oct; 63(10):2026-2039. PubMed ID: 38990091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-cancer effects of nitazoxanide in epithelial ovarian cancer in-vitro and in-vivo.
    Yang X; Liu Z; Wang X; Tian W; Zhao T; Yang Q; Li W; Yang L; Yang H; Jia Y
    Chem Biol Interact; 2024 Sep; 400():111176. PubMed ID: 39084502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ursolic acid inhibits the proliferation of human ovarian cancer stem-like cells through epithelial-mesenchymal transition.
    Zhang J; Wang W; Qian L; Zhang Q; Lai D; Qi C
    Oncol Rep; 2015 Nov; 34(5):2375-84. PubMed ID: 26323892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YYB-101, a Humanized Antihepatocyte Growth Factor Monoclonal Antibody, Inhibits Ovarian Cancer Cell Motility and Proliferation.
    Kim HJ; Heo K
    Anticancer Res; 2021 Feb; 41(2):671-678. PubMed ID: 33517271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibitory effect of doxycycline on cisplatin-sensitive and -resistant epithelial ovarian cancer.
    Wu W; Yu LH; Ma B; Xu MJ
    PLoS One; 2014; 9(3):e89841. PubMed ID: 24598933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMAD3 inducing the transcription of  STYK1 to promote the EMT process and improve the tolerance of ovarian carcinoma cells to paclitaxel.
    Shi Y; Zhang J; Liu M; Huang Y; Yin L
    J Cell Biochem; 2019 Jun; 120(6):10796-10811. PubMed ID: 30701575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forkhead Box Protein C2 Promotes Epithelial-Mesenchymal Transition, Migration and Invasion in Cisplatin-Resistant Human Ovarian Cancer Cell Line (SKOV3/CDDP).
    Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M
    Cell Physiol Biochem; 2016; 39(3):1098-110. PubMed ID: 27562816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
    Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sialyltransferase ST3GAL1 promotes cell migration, invasion, and TGF-β1-induced EMT and confers paclitaxel resistance in ovarian cancer.
    Wu X; Zhao J; Ruan Y; Sun L; Xu C; Jiang H
    Cell Death Dis; 2018 Oct; 9(11):1102. PubMed ID: 30375371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bufalin inhibits ovarian carcinoma via targeting mTOR/HIF-α pathway.
    Su S; Dou H; Wang Z; Zhang Q
    Basic Clin Pharmacol Toxicol; 2021 Feb; 128(2):224-233. PubMed ID: 32905663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selenium-enriched polysaccharides from Pyracantha fortuneana (Se-PFPs) inhibit the growth and invasive potential of ovarian cancer cells through inhibiting β-catenin signaling.
    Sun Q; Dong M; Wang Z; Wang C; Sheng D; Li Z; Huang D; Yuan C
    Oncotarget; 2016 May; 7(19):28369-83. PubMed ID: 27058760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-146b promotes cell proliferation and increases chemosensitivity, but attenuates cell migration and invasion via FBXL10 in ovarian cancer.
    Yan M; Yang X; Shen R; Wu C; Wang H; Ye Q; Yang P; Zhang L; Chen M; Wan B; Zhang Q; Xia S; Lu X; Shao G; Zhou X; Yu J; Shao Q
    Cell Death Dis; 2018 Nov; 9(11):1123. PubMed ID: 30409964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Triptolide-Loaded Exosomes on the Proliferation and Apoptosis of Human Ovarian Cancer SKOV3 Cells.
    Liu H; Shen M; Zhao D; Ru D; Duan Y; Ding C; Li H
    Biomed Res Int; 2019; 2019():2595801. PubMed ID: 31240207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LY75 Suppression in Mesenchymal Epithelial Ovarian Cancer Cells Generates a Stable Hybrid EOC Cellular Phenotype, Associated with Enhanced Tumor Initiation, Spreading and Resistance to Treatment in Orthotopic Xenograft Mouse Model.
    Mehdi S; Macdonald E; Galpin K; Landry DA; Rodriguez G; Vanderhyden B; Bachvarov D
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32679765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low expression of FXYD5 reverses the cisplatin resistance of epithelial ovarian cancer cells.
    Liu YK; Jia YJ; Liu SH; Shi HJ; Ma J
    Histol Histopathol; 2021 May; 36(5):535-545. PubMed ID: 33570156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer Effects of BAF312 (Siponimod) in Epithelial Ovarian Cancer.
    Ha H; Ryu JY; Yoon S; Cho YJ; Choi JJ; Hwang JR; Choi JY; Han HD; Lee JW
    Anticancer Res; 2024 Oct; 44(10):4273-4282. PubMed ID: 39348952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COM33 suppresses carboplatin-induced epithelial-mesenchymal transition via inhibition of Twist1 in ovarian cancer.
    Zhou Z; Jin L; Shen J; Shi W; Xu Y; Ye L; Liu J; Pan J
    Acta Biochim Biophys Sin (Shanghai); 2022 Dec; 55(1):34-42. PubMed ID: 36647720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.